Charles Schwab Investment Management »

Bright Minds Biosciences shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $704k 12k 60.66
2025-06-30 $303k 12k 26.11

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Intl (FNDF)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Charles Schwab Investment Management

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Commodore Capital
Perceptive Advisors
Adage Capital Partners GP
Braidwell
BlackRock
Sio Capital Management
Balyasny Asset Management
Morgan Stanley
Point72 Asset Management
Longwood Capital Partners
Millennium Management
Walleye Trading Advisors

View all funds holding Bright Minds Biosciences